Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Patterns of Referral

NCT ID: NCT02093975

Last Updated: 2015-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physician manned rapid response vehicles are a limited resource in the prehospital handling of acute patients.

In this study mobile videoconferencing between ambulances and the rapid response vehicles enables patient consultation at a distance. Video consultation between patient and the prehospital physician can take place when the patient is at home or in the ambulance.

The primary aim of this study is to examine the effect of video consultation between physician manned rapid response vehicles and patients receiving treatment by ambulance personnel on the number of patients receiving final treatment on-site in the pre-hospital setting

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

All Acutely Ill or Injured Patients Receiving Care by Ambulance Personnel

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video consultation

Patients in this arm receive video consultation from physician in doctor manned rapid response vehicle.

Group Type EXPERIMENTAL

iPad air with 4G/3G SIM card

Intervention Type DEVICE

iPad air with 4G/3G SIM card is used as device for videoconferencing. LifeSizeClearSea solution is used for videoconferencing.

Video consultation

Telephone consultation

Patients receiving prehospital care by ambulance personnel whom receive telephone consultation/supervision by physician in rapid response vehicle.

Group Type ACTIVE_COMPARATOR

iPad air with 4G/3G SIM card

Intervention Type DEVICE

iPad air with 4G/3G SIM card is used as device for videoconferencing. LifeSizeClearSea solution is used for videoconferencing.

Video consultation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iPad air with 4G/3G SIM card

iPad air with 4G/3G SIM card is used as device for videoconferencing. LifeSizeClearSea solution is used for videoconferencing.

Video consultation

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LifeSizeClearSea

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients receiving prehospital care by ambulance personnel
* Must receive either telephone or video consultation by physician in rapid response vehicle

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Denmark Region

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nikolaj Raaber

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nikolaj Raaber, MD

Role: PRINCIPAL_INVESTIGATOR

Central Denmark Region

Erika Christensen, MD, medical director

Role: STUDY_DIRECTOR

Central Denmark Region

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lægebilen, Hospitalsenheden Horsens

Horsens, , Denmark

Site Status

Responce A/S

Horsens, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NRAA3

Identifier Type: -

Identifier Source: org_study_id